Craig Hopkinson is the EVP of Research and Development and CMO at Alkermes, bringing nearly 30 years of experience in clinical development and medical affairs. He has expertise across neuroscience, oncology, and rare diseases, leading teams at Vertex, Eisai, and Pfizer. He earned his MD from the University of the Free State.
He is passionate about mentoring the next generation of researchers, spearheading the Alkermes Pathways Research Awards to support early-career scientists. His leadership is described as inspiring, and he encourages his teams to take risks, foster innovation, and challenge the status quo to achieve breakthroughs.
He was named a "Trailblazer" in the 2024 PharmaVoice 100 list for his commitment to patients and leadership.
Read the full overview →Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.
Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.
Explore more public profiles from related professionals.
Discover additional public profiles from our index.
Looking for someone else? Search here for anyone.